We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
BIO-RAD LABORATORIES

Download Mobile App




基态人类干细胞促进再生医学和人类发展的研究

By LabMedica International staff writers
Posted on 03 Dec 2013
Print article
发现了一种维持人类诱导多能干细胞(iPS 细胞)最早期、最原始、最基态的方法,预期该方法能促进这些干细胞在再生医学、患者特定 iPS 细胞疾病模型,以及在早期人类发展的体外和体内研究中的应用。

诱导多能干细胞形成的方法通常为:向诸如皮肤细胞的此类成人细胞基因组中插入 4 个基因,然后使用鸡尾酒式组合的生长因子培养改良的细胞。然后分化的细胞还原为胚胎干细胞类似状态,而不是成为多种不同细胞类型的成熟细胞。此问题的症结在于,缺乏将干细胞长期保持在未分化状态的方法。

Weizmann Institute of Science (Rehovot, Israel) 的研究人员使用小鼠和人类细胞进行研究,努力解决此问题。他们尤其感兴趣建立一种技术,将人类的 iPS 细胞保持在最早期基态,以模拟小鼠的干细胞行为,后者能更长时间自然的保持未分化状态。

研究人员在 2013 年 10 月 30 日的《自然杂志》(Nature) 网络版中报道,已成功确立了指定条件,以便于将已经成为始发态人类胚胎干细胞的细胞衍生为未经基因改良的人类基态多能干细胞、经由 iPS 细胞重新编程从体细胞衍生为未经基因改良的人类基态多能干细胞,或直接从囊胚泡衍生为未经基因改良的人类基态多能干细胞。新的基态多能细胞保留了与小鼠基态胚胎干细胞高度相似的分子特性和功能特性,并有别于普通的始发人类多能干细胞。

Related Links:
Weizmann Institute of Science

Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Magnetic Bead Separation Modules
MAG and HEATMAG
Complement 3 (C3) Test
GPP-100 C3 Kit
New
Gold Member
Magnetic Bead Separation Modules
MAG and HEATMAG

Print article

Channels

Clinical Chemistry

view channel
Image: The 3D printed miniature ionizer is a key component of a mass spectrometer (Photo courtesy of MIT)

3D Printed Point-Of-Care Mass Spectrometer Outperforms State-Of-The-Art Models

Mass spectrometry is a precise technique for identifying the chemical components of a sample and has significant potential for monitoring chronic illness health states, such as measuring hormone levels... Read more

Molecular Diagnostics

view channel
Image: A blood test could predict lung cancer risk more accurately and reduce the number of required scans (Photo courtesy of 123RF)

Blood Test Accurately Predicts Lung Cancer Risk and Reduces Need for Scans

Lung cancer is extremely hard to detect early due to the limitations of current screening technologies, which are costly, sometimes inaccurate, and less commonly endorsed by healthcare professionals compared... Read more

Hematology

view channel
Image: The CAPILLARYS 3 DBS devices have received U.S. FDA 510(k) clearance (Photo courtesy of Sebia)

Next Generation Instrument Screens for Hemoglobin Disorders in Newborns

Hemoglobinopathies, the most widespread inherited conditions globally, affect about 7% of the population as carriers, with 2.7% of newborns being born with these conditions. The spectrum of clinical manifestations... Read more

Immunology

view channel
Image: Exosomes can be a promising biomarker for cellular rejection after organ transplant (Photo courtesy of Nicolas Primola/Shutterstock)

Diagnostic Blood Test for Cellular Rejection after Organ Transplant Could Replace Surgical Biopsies

Transplanted organs constantly face the risk of being rejected by the recipient's immune system which differentiates self from non-self using T cells and B cells. T cells are commonly associated with acute... Read more

Microbiology

view channel
Image: The real-time multiplex PCR test is set to revolutionize early sepsis detection (Photo courtesy of Shutterstock)

1 Hour, Direct-From-Blood Multiplex PCR Test Identifies 95% of Sepsis-Causing Pathogens

Sepsis contributes to one in every three hospital deaths in the US, and globally, septic shock carries a mortality rate of 30-40%. Diagnosing sepsis early is challenging due to its non-specific symptoms... Read more

Pathology

view channel
Image: The QIAseq xHYB Mycobacterium tuberculosis Panel uses next-generation sequencing (Photo courtesy of 123RF)

New Mycobacterium Tuberculosis Panel to Support Real-Time Surveillance and Combat Antimicrobial Resistance

Tuberculosis (TB), the leading cause of death from an infectious disease globally, is a contagious bacterial infection that primarily spreads through the coughing of patients with active pulmonary TB.... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.